This report offers companies, investors, policymakers, and stakeholders crucial insight into the rich ecosystem of pharmaceuticals, biotech, and healthcare companies in Mexico, based on in-depth interviews conducted with leaders and pioneers across the value chain, from the secretary of health to heads of the various Mexican social security institutes, country managers of the world’s leading biopharmaceutical companies, and representatives from innovative local SMEs and service providers.

Healthcare & Life Sciences Review Mexico 2017 features sections on Mexico’s macroeconomic situation, healthcare, regulatory reform, pharma market, strategy, key therapeutic areas, manufacturing, clinical research, medtech, and logistics and distribution.